Trials / Sponsors / Immtech Pharmaceuticals, Inc
Immtech Pharmaceuticals, Inc
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subj Healthy | Phase 1 | 2007-11-01 |
| Completed | Prophylactic Antimalarial Activity of DB289 in Volunteers Prophylactic Activity Against Malaria | Phase 1 / Phase 2 | 2006-11-01 |
| Terminated | DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) Pneumonia, Interstitial Plasma Cell, Pneumocystis Carinii Pneumonia, Pneumonia, Pneumocystis Carinii | Phase 3 | 2006-05-01 |
| Completed | Trial of DB289 for the Treatment of Stage I African Trypanosomiasis African Trypanosomiasis | Phase 2 | 2003-02-01 |
| Completed | A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis Trypanosomiasis, African | Phase 2 | 2001-08-01 |